The deal is part of a partnership announced March 7, which connects Mark Cuban’s drug manufacturing facility in Dallas to nine hospitals owned by Franklin, Tenn.-based Community Health Systems.
“This milestone marks the beginning of our effort to tackle the national shortage and ensure essential medications are accessible at fair prices,” Cost Plus Drugs said in an April 18 post on X.
The nine hospitals also expect deliveries of norepinephrine. Both medications are manufactured in specialized vial sizes, which were designed for hospital use. This summer, the 20,000-square-foot manufacturing plant will begin producing four chemotherapies in short supply: vinblastine, cisplatin, methotrexate and dacarbazine.
CHS is currently the only health system to partner with Cost Plus Drugs.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
